Chemical Structure Searching for the Array of Pharmaceutical Intelligence Tools
News Sep 05, 2005
Wolters Kluwer Health has announced a partnership with CambridgeSoft of Cambridge, Mass., to market chemical structure search tools for drug discovery scientists and pharmaceutical chemists.
At the annual meeting of the American Chemical Society (ACS), the companies demonstrated their first joint product, a software module that is designed to allow scientists to use ChemDraw®, the chemical-drawing software, to search by chemical structure for all of the compounds in the existing Adis R&D Insight® database.
Marketed by Wolters Kluwer Health, Adis R&D Insight is the industry's authoritative pipeline intelligence tool that is designed to feature a database of 20,000 compounds.
CambridgeSoft's technology is designed to convert chemical compound names into their associated chemical structures and makes them searchable.
According to Wolters, using the module, drug discovery scientists can query the vast, text-based Adis R&D Insight database using their own language and the resulting benefit is that users can evaluate a structure in the context of related compounds.
"Using our new structure searching module, scientists can check to see if a target molecule is already in development or if it's near clinical trials," said John Monahan, President and CEO of Wolters Kluwer Health, Pharma Solutions.
He adds, "By harnessing the power of ChemDraw and Adis R&D Insight, we've made it easier for scientists to identify a potentially competitive compound earlier in the development process."
"CambridgeSoft is pleased to be partnering with Wolters Kluwer Health," said Michael G. Tomasic, Chairman and CEO of CambridgeSoft.
He adds, "Combining content provided by Wolters Kluwer Health with the leading chemical structure search technology, including ChemOffice and ChemDraw, from CambridgeSoft enhances the ability of the scientific community to search, analyze, and make decisions relevant to the direction of the research."
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE